How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,018 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Access to Hormonal Contraception

- tinued their pill use (P5.12) (20). Additionally, when adjustingfordifferences(age,countryofbirth,country where education was completed, U.S. health insurance status, receipt of government assistance, border- crossing frequency, duration of use of OCPs, experi- ence of adverse effects attributable to OCPs, and how long the woman reported she planned to use OCPs), a higher rate of discontinuation for women who ob- tained pills in El Paso clinics (25.1%) compared with those who obtained their pills (...) purchased combined OCPs over-the-counter in this study did not self-screen using a standardized process and the circumstances of patients (eg, lacking access to primary care) may have affected the outcome. Pharmacist screening for behind-the-counter access to hormonal contraceptive methods also has been evaluated. In the Direct Access Study, several pharma- cists received specialized education in the provision of hormonal contraceptive methods and were authorized to provide hormonal contraception

2019 American College of Obstetricians and Gynecologists

162. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Full Text available with Trip Pro

Health Education Consortium, Joint-Base San Antonio, Texas , MD y , x Jashin J. Wu Affiliations Dermatology Research and Education Foundation, Irvine, California , MD z , x Vidhya Hariharan Affiliations American Academy of Dermatology, Rosemont, Illinois Correspondence Correspondence to: Vidhya Hariharan, PhD, 9500 W Bryn Mawr Ave, Rosemont, IL 60018. , PhD aa , ∗ , x Vidhya Hariharan Affiliations American Academy of Dermatology, Rosemont, Illinois Correspondence Correspondence to: Vidhya Hariharan (...) inhibitor. ---- | Fig 5 From: Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation . 2013 ( ). x 87 Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report

2019 American Academy of Dermatology

163. Management of Stroke Rehabilitation

- specific goals, values, and preferences. B. Guide patients on self-management during stroke rehabilitation as well as on use of other resources that are available to assist them with their ADLs. C. Assist patients with navigating the complex health system. D. Provide patients and family, and their caregivers with education and health information to improve understanding of stroke, common comorbidities, and stroke rehabilitation management. Materials need to be individualized to preferred learning (...) comprehensive care and rehabilitation starting early in the post-acute phase. G. Create a support system for patients with stroke and their caregivers. Suggested actions include monthly provider-facilitated meetings either in-person or online groups, other support groups, and stroke education classes to enhance involvement and support among patients with stroke. H. Screen for, identify, and treat post-stroke depression. I. Provide home care and community support resources to optimize quality of life

2019 VA/DoD Clinical Practice Guidelines

164. Integrated care for older people (?ICOPE)?: guidance for person-centred assessment and pathways in primary care

the combined impact of rapidly falling fertility rates and rapidly increasing life expectancy in much of the world, often accompanying socioeconomic development. Maintaining the health of older people is an investment in human and social capital and supports the United Nations Sustainable Development Goals (SDGs) (4). At the same time, caring for the growing older population creates challenges for health systems. Health-care resources will need to be rebalanced across age groups. A fundamental change (...) (palliative care, rehabilitation) or to ensure that older people can continue to live lives of meaning and dignity; • social care and support, including environmental adaptations, to compensate for any functional losses; and • a plan to meet social care needs with the help of family members, friends and community services. Health and social care workers can support the implementation of the care plan in the community or the primary care setting. Self-management, supported by advice, education

2019 World Health Organisation Guidelines

165. American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations Full Text available with Trip Pro

muscle IMAT (area), paraspinal IMAT (area), and psoas IMAT (area) (CT) Time between body composition cholesterol, tests not stated Spearman correlations reported There were significant correlations between % BF (DXA) and VAT (area), SAT (area), abdominal muscle IMAT (area), paraspinal IMAT (area), and psoas IMAT (area) (CT) (all P ‐values < 0.0001) Mourtzakis et al, 2008 To evaluate regional CT images acquired during routine patient care as a potential resource to discriminate and to quantify (...) reported There were significant correlations between FM (DXA) vs TAAT (CT), FM (DXA) vs TSAT (CT), FM (DXA) vs SSAT (CT), and FM (DXA) vs VAT (CT) (all P ‐values < 0.0001) There were significant correlations between total cholesterol, total triglycerides, total ApoB, VLDL cholesterol, VLDL triglycerides, ApoB, LDL cholesterol, LDL triglycerides, and LDL ApoB vs VAT (CT) (all P ‐values < 0.0001) There were significant correlations between HDL cholesterol ( P = 0.02), HDL triglcerides ( P = 0.002), HDL2

2019 American Society for Parenteral and Enteral Nutrition

166. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims: An Official ATS Policy Statement

of subjects by discussing the unique nature of risk inherent to harm reduction protocols. Promoting an understanding suf?cient for subjects to legitimately assume risk protects subjects from unforeseen or tragic consequences of participation through fairmethodsthatpromotejustoutcomes. d Harm reduction policies should state the perspective(s) from which they are derived, guard against inequitable allocation of resources, provide assurance of longitudinal surveillance, and inform the public of important (...) Volume 198 Number 8 | October 15 2018 normalize safe ride techniques such as designated drivers. Safer sex education aimed at teen students has reduced transmission of infectious disease, decreased teen pregnancy rates, and promoted safer sexual decision making among those engaged in sexual activity (16, 17). Alternatively, harm reduction strategies have also focused on minimizing the sequelae of exposures, without directly impacting behaviors. Examples include free or low-cost HIV testing

2019 American Thoracic Society

167. BTS Guideline for Bronchiectasis in adults

be taught by a respira- tory physiotherapist. ? At initial assessment, a respiratory physiotherapist should educate the patient about their condition and if appropriate give advice on adjuncts (inhaled/oral therapy or exercise) that may enhance effectiveness of their chosen airway clear- ance technique. ? Patients admitted with an exacerbation of bronchiectasis should be seen daily by a respiratory physiotherapist until their airway clearance is optimised. Which airway clearance techniques should

2019 British Thoracic Society

168. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

. Welty , Originally published 10 Dec 2018 Arteriosclerosis, Thrombosis, and Vascular Biology. 2018;39:e38–e81 Abstract One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cholesterol of 55% to 60% at the maximum dosage, and 6 of the 7 marketed statins are available in generic form, which makes them affordable (...) of these events is a priority. Overall, in patients for whom statin treatment is recommended by current guidelines, the benefits greatly outweigh the risks. The development and use of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin) class of drugs, which, according to the prescribing information, reduce low-density lipoprotein cholesterol (LDL-C) on average by 55% to 60% at the maximal doses of the most potent statins, has had a major impact in reducing the incidence

2019 American Gastroenterological Association Institute

169. Prepregnancy counseling

supplementation should be encouraged to reduce the risk of neural tube defects. (Fertil Steril 2019;111:32–42.2018 by the American College of Obstetricians and Gynecologists.) ACOGCOMMITTEEOPINION NUMBER762 CommitteeonGynecologic Practice AmericanSocietyfor ReproductiveMedicine This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper (...) , address modi?able risk factors, and provide education about healthy pregnancy. All those planning to initiate a pregnancy should be counseled, including heterosexual, lesbian, gay, bisexual, transgender, queer, intersex, asexual, and gender nonconforming individuals. Counseling can begin with the following question: ‘‘Would you like to become pregnant in the next year?’’ Prepregnancy counseling is appropriate whether the reproductive-aged patient is currently using contraception

2019 Society for Assisted Reproductive Technology

170. Ethical Considerations for the Care of Patients With Obesity

, MA. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating (...) clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. Any updates to this document can be found on or by calling the ACOG Resource Center. While ACOG makes every effort to present accurate and reliable information, this publication is provided

2019 American College of Obstetricians and Gynecologists

171. Prepregnancy Counseling

is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action (...) is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. Any updates to this document can be found on or by calling the ACOG Resource Center. While ACOG makes every effort to present accurate and reliable information, this publication is provided "as is" without any warranty

2019 American College of Obstetricians and Gynecologists

172. Heart Disease and Stroke Statistics Full Text available with Trip Pro

(smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and glucose control) that contribute to cardiovascular health. The Statistical Update represents a critical resource for the lay public, policy makers, media professionals, clinicians, healthcare administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions. Cardiovascular disease (CVD) produces immense health and economic burdens in the United (...) Texas Health Resources Clinical Scholarship None None None None None None Amanda M. Perak Lurie Children’s None None None None None None None Wayne D. Rosamond Gillings School of Global Public Health, University of North Carolina, Department of Epidemiology None None None None None None None Gregory A. Roth University of Washington, Department of Medicine–Cardiology NHLBI ; Cardiovascular Medical Research and Education Foundation None None None None None None Uchechukwu K.A. Sampson New York

2019 American Heart Association

173. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned

of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients. This report is made available to the public under the terms of a licensing agreement between the authors and the Agency for Healthcare Research and Quality. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted (...) : Measure Definitions and Data Element Descriptions 13 Development of Standardized Terminologies 13 Leveraging Existing Resources 14 Public Comment 15 Challenges and Lessons Learned 16 Next Steps 16 Implementation 16 Dissemination 17 Ongoing Governance 17 Additional Clinical Areas 17 References 19 Abbreviations 21 Tables Table 1. Steps in registry identification process 6 Table 2. Stakeholder participation rationale 8 Table 3. Registry and stakeholder organization participation, by clinical area 8 Table

2019 Effective Health Care Program (AHRQ)

174. Use of patient-reported outcome and experience measures in patient care and policy

of healthcare which are, mostly, improving patients’ health, minimising disability and improving quality of life. [2, 3] The development and use of patient reported outcome measures (PROM) and patient reported experience measures (PREM) is growing to obtain this information (see 1.2 for a detailed description of these concepts). PROMs and PREMs co-exist next to other outcome measures (e.g. progression-free survival, cholesterol level, blood pressure) and are meant for the measurement of outcomes for which (...) empowerment PROMs and PREMs are usually applied in the context of a larger endeavour to improve patient participation, patient-centeredness and patient empowerment, alongside other instruments such as patient panels, qualitative interviews with patients, patient education and patient diaries. Patient empowerment is a broader concept than patient participation and patient-centeredness. [16] The relationship between these concepts was nicely summarized by Castro et al. as follows: ”by focusing on patient

2018 Belgian Health Care Knowledge Centre

175. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada

, FRCPC, FACE, Yvonne Mullan MSc, RD, CDE Management S27 Organization of Diabetes Care Maureen Clement MD, CCFP, Pierre Filteau MD, CFPC, CMFC, Betty Harvey RN(EC), BScN, MScN, Susie Jin RPh, CDE, CPT BCGP, Tessa Laubscher MBChB, CCFP, FCFP, Geetha Mukerji MD, MSc, FRCPC, Diana Sherifali RN, PhD, CDE S36 Self-Management Education and Support Diana Sherifali RN, PhD, CDE, Lori D. Berard RN, CDE, Enza Gucciardi PhD, Barbara MacDonald RN, BSN, MS-DEDM, CDE, Gail MacNeill BNSc, RN, MEd, CDE S42 Targets (...) , University of Manitoba, Winnipeg, MB 2018 Clinical Practice Guidelines Committees The following committee members contributed to the development of the Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Robyn L. Houlden MD FRCPC Chair Professor and Chair Division of Endocrinology and Metabolism, Department of Medicine, Queen’s University, Kingston, ON Lori Berard RN CDE Advisor Diabetes Educator Clinical Research Consultant, Winnipeg, MB Alice Y.Y

2018 Diabetes Canada

176. Pharmacological management of glycaemic control in people with type 2 diabetes

36 13.1 Implementation strategy 36 13.2 Resource implications of key recommendations 36 13.3 Auditing current practice 36 13.4 Health technology assessment advice for NHSScotland 36 14 The evidence base 37 14.1 Systematic literature review 37 14.2 Recommendations for research 38 15 Development of the guideline 39 15.1 Introduction 39 15.2 The guideline development group 39 15.3 Consultation and peer review 40 Abbreviations 42 Annex 1 45 References 46 Pharmacological management of glycaemic (...) (hyperglycaemia) is also one of the features of diabetes, along with raised blood pressure and cholesterol, which is associated with macrovascular complications (myocardial infarction, stroke, and peripheral arterial disease). The effects of glucose-lowering therapies on cardiovascular morbidity and mortality are therefore of major importance and not necessarily related to glucose lowering. Until 2010, the majority of clinical trials focused narrowly on glucose control (as assessed by HbA1c (glycated

2017 SIGN

177. Cardiac rehabilitation

concordance 20 9 Provision of information 21 9.1 Checklist for provision of information 21 9.2 Sources of further information 22 10 Implementing the guideline 25 10.1 Implementation strategy 25 10.2 Resource implications of key recommendations 25 10.3 Auditing current practice 25 11 The evidence base 26 11.1 Systematic literature review 26 11.2 Recommendations for research 26 11.3 Review and updating 27 12 Development of the guideline 28 12.1 Introduction 28 12.2 The guideline development group .28 12.3 (...) replaces the old four phase model with a 0–6 stage pathway including individualised assessment and care planning. 4 The standards describe a biopsychosocial approach to CR in which the overall aim is to equip the patient with the necessary knowledge and skills to enable them to successfully self manage their condition to live a longer, healthier, and more independent life. The approach is centred on patient education using health behaviour change techniques, which are patient centred and sensitive both

2017 SIGN

178. Risk estimation and the prevention of cardiovascular disease

and the prevention of cardiovascular disease Contents9.4 Antiplatelet agents for people with hypertension 38 9.5 Antiplatelet agents for people with chronic kidney disease 38 10 Lipid lowering 39 10.1 The role of total and low-density lipoprotein cholesterol in cardiovascular disease 39 10.2 Measuring lipid levels 39 10.3 Lowering cholesterol to reduce cardiovascular risk 40 10.4 Statin therapy 40 10.5 Special considerations 48 10.6 Other lipid-lowering agents 51 10.7 Management of combined dyslipidaemia 55 11 (...) Implementing the guideline 74 14.1 Implementation strategy 74 14.2 Resource implications of key recommendations 74 14.3 Auditing current practice 74 14.4 Health technology assessment advice for NHSScotland 75 15 The evidence base 76 15.1 Systematic literature review 76 15.2 Recommendations for research 77 16 Development of the guideline 78 16.1 Introduction 78 16.2 The guideline development group 78 16.3 The steering group 79 16.4 Consultation and peer review 80 Abbreviations 82 Annexes 85 References 99

2017 SIGN

179. Evaluation and Management of Testosterone Deficiency

. Ramanathan, PhD; Ronald W. Lewis, MD Copyright © 2018 American Urological Association Education and Research, Inc.® 2 American Urological Association (AUA) Guideline Statements Diagnosis of Testosterone Deficiency 1. Clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone. (Moderate Recommendation; Evidence Level: Grade B) 2. The diagnosis of low testosterone should be made only after two total testosterone measurements (...) Recommendation; Evidence Level: Grade B) Evaluation and Management of Testosterone Deficiency Copyright © 2018 American Urological Association Education and Research, Inc.® 3 14. Patients should be informed that testosterone therapy may result in improvements in erectile function, low sex drive, anemia, bone mineral density, lean body mass, and/or depressive symptoms. (Moderate Recommendation; Evidence Level: Grade B) 15. Patients should be informed that the evidence is inconclusive whether testosterone

2018 American Urological Association

180. Erectile Dysfunction

. Nelson, PhD; Hossein Sadeghi-Nejad, MD; Allen D. Seftel, MD; Alan W. Shindel, MD Copyright © 2018 American Urological Association Education and Research, Inc.® The Panel would like to dedicate this Guideline to the memory of our friend and colleague, Ralph Alterowitz. We will forever be grateful to his contributions and devotion to the field of men’s sexual health. He brought compassion and joy to all of those who were fortunate enough to work with him. 2 American Urological Association (AUA (...) ) Copyright © 2018 American Urological Association Education and Research, Inc.® Guideline Statements: Evaluation and Diagnosis: 1. Men presenting with symptoms of ED should undergo a thorough medical, sexual, and psychosocial history; a physical examination; and selective laboratory testing. (Clinical Principle) 2. For the man with ED, validated questionnaires are recommended to assess the severity of ED, to measure treat- ment effectiveness, and to guide future management. (Expert Opinion) 3. Men should

2018 American Urological Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>